Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
Under the guise of trying to lower drug prices, the FTC is attempting to extend its reach and authority into new channels Several drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical companies that it alleges are trying to …